Hervycta 440mg Injection: Effective Treatment Solution

Active constituent: Trastuzumab

Indications:

• Advanced and metastatic breast cancer (HER2 positive patients).
• Metastatic gastric cancer with increased levels of HER2 proteins.

Mechanism of action:

• Selectively binds to HER2 proteins, stopping the growth of cancer cells.

Administration:

• Intravenous infusion for 90 minutes, then 30 minutes for subsequent doses if well tolerated.
• Administered before or after surgery.

Safety advice:

• Pregnancy: discuss with your physician before taking; avoid unless advised by doctor.
• Breastfeeding: avoid breastfeeding while on treatment and for at least 7 months after the final dose.
• Lungs: consult your doctor if you have any lung conditions.
• Liver: inform your physician of any liver disorders for dosage adjustment.
• Alcohol: consult your doctor about alcohol consumption during treatment.
• Driving: avoid driving or handling machinery due to potential dizziness and tiredness.

Side effects:

• Serious: heart problems, allergic reactions, kidney problems, breathing difficulties.
• Common: fever, visual disturbances, nose bleeds or runny nose, hair loss, dizziness, nail disorders, weight loss, loss of appetite, bruising, dry mouth, liver inflammation, muscle pain, asthma/lung disorders.

Interaction with other drugs:

• Inform your doctor about all medications, supplements, and herbal products you are taking.

Contraindications:

• Not recommended for patients under 18, those with severe breathing problems, or those needing oxygen treatment.

Additional information:

• Keep out of sight and reach of children.
• Store between 2°C and 8°C.

FAQ:

• Q1: Is Hervycta 440mg Injection used as a monotherapy in treating breast cancer? A: No, it is generally given with chemotherapy medications or hormonal agents.

• Q2: Does Hervycta 440mg Injection cause heart problems? A: Yes, it can damage heart muscles, so regular heart check-ups are advised.

• Q3: Can I breastfeed while on treatment with Hervycta 440mg Injection? A: No, it is unsafe to breastfeed while on this treatment and for at least 7 months after the last dose.

• Q4: Can Hervycta 440mg Injection be consumed during pregnancy? A: No, it can harm the baby and is unsafe during pregnancy.

Fact box:

• Molecule name: Trastuzumab
• Therapeutic class: Anti-cancer
• Pharmacological class: HER2 inhibitor

Tags: Hervycta, Injection, 440mg, Medical, Drug, Medication, Healthcare, Pharmaceuticals